Search Results
Results found for "positive allosteric modulators"
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations
- Dr. GPCR Board | Dr. GPCR Ecosystem
critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models San Diego Supercomputer Center, and provided consultation for genetic sequence analysis, molecular modeling
- Dr. Kathleen Caron | Dr. GPCR Ecosystem
steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
10:00 β₂-adrenergic receptors and muscle physiology 15:00 Exercise, metabolism, and pharmacological modulation
- GPCR Weekly News | Dr. GPCR Ecosystem
Premium members get the complete intelligence. iPSC-Derived GPCR Models — Terry Hébert Live April 16
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
critical expertise, and rigorous approaches to examine PAR1 function using human cultured cells and mouse models
- Dr. Simone Prömel & Dr. Ines Liebscher | Dr. GPCR Ecosystem
different signals on a molecular level and how these are translated into physiological functions in various model
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
interested in translational innovation Biotech investors and strategic leaders seeking new drug development models
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
The result was a structured group management model built around four specialized subgroups, each with 15 - subgroups, leadership training, and delegation 40:41 What excites Gloriam today - open science models
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model
- Dr. GPCR Team | Dr. GPCR Ecosystem
Currently serving as a Post Doctoral research fellow at Monash University, John plays a pivotal role elucidating the molecular basis of membrane protein signalling using quantitative assays and molecular modelling
- Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
Gutkind a pre-built mental model for what to freeze, what to protect, and what to let continue.
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
Her lab uses homology modeling, machine learning, and collaborative sensory experiments to predict bitterness safety, and pharmacokinetics - but bitterness prediction was rarely incorporated until clinical or even post-market
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
📌 Measuring Bias: A Quantitative Approach 🔹 The operational model provides a structured way to measure
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
The system is modular and adaptable, opening doors for systems biology and context-specific interaction













